Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| (±)-10-Hydroxycamptothecin | (±)-10-Hydroxycamptothecin is an alkaloid derived from the seed or root bark of the deciduous plant Camptotheca acuminata. It has selective inhibitory effect on the phosphorylation of histone H1 and H3, but less effect on other histones. It exhibits anticancer and antiangiogenic activities. It can be used in cosmetics material. Group: Pharmaceutical. Alternative Names: 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4,9-dihydroxy-; 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4,9-dihydroxy-, (±)-; (+/-)-10-Hydroxycamptothecin; 4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione. CAS No. 64439-81-2. Pack Sizes: 1 g. Product ID: B2703-051417. Molecular formula: C20H16N2O5. Mole weight: 364.35. Custom synthesis is available. Send your inquiries for more information. |  London |
| 16-Hydroxycleroda-3,13-dien-15,16-olide | 16-Hydroxycleroda-3,13-dien-15,16-olide is extracted from the unripe fruits of Polyalthia longifolia var. pendula. It is used as a candidate for autophagy inducers which can cause cell death in an alternative or supplement medicine for cancer therapy. It displays promising NO inhibitory activity at 10 ug/mL and shows anti-inflammatory activity. It induces apoptosis in CML K562 cells and regulates the expression of histone-modifying enzymes PRC2 complex. Group: Pharmaceutical. Alternative Names: 5-Hydroxy-4-[2-[[(1S)-1,2,3,4,4a,7,8,8abeta-octahydro-1alpha,2alpha,4aalpha,5-tetramethylnaphthalen]-1-yl]ethyl]furan-2(5H)-one. CAS No. 141979-19-3. Pack Sizes: 1 mg. Product ID: NP1411. Molecular formula: C20H30O3. Mole weight: 318.45. Custom synthesis is available. Send your inquiries for more information. | London |
| A 196 | A 196 is a potent and selective inhibitor of SUV420H1/H2 (IC50 = 25 and 144 nM, respectively) with 100-fold selectivity over other histone methyltransferases and non-epigenetic targets. It was shown to inhibit the di- and tri-methylation of H4K20me in multiple cell lines (IC50 < 1 μM). Group: Pharmaceutical. Alternative Names: SGC A-196; SGC A 196; SGC A196; SGC-A-196; SGCA196; A-196; A 196; A196; 6,7-Dichloro-N-cyclopentyl-4-(4-pyridinyl)-1-phthalazinamine. CAS No. 1982372-88-2. Pack Sizes: 1mg;1g;10g. Product ID: 1982372-88-2. Molecular formula: C18H16Cl2N4. Mole weight: 359.25. Custom synthesis is available. Send your inquiries for more information. | London |
| A-366 | A-366 is a peptide-competitive inhibitor of the G9a/GLP histone lysine methyltransferase (IC50 = 3.3 nM) and is approximately 1000-fold selective over other methyltransferases. Group: Pharmaceutical. Alternative Names: A 366; A366. CAS No. 1527503-11-2. Pack Sizes: 100 mg. Product ID: B2693-474604. Molecular formula: C19H27N3O2. Mole weight: 329.44. Custom synthesis is available. Send your inquiries for more information. | London |
| A-485 | A-485 is an inhibitor of the histone acetyltransferase p300/CBP (IC50 = 60 nM). Group: Pharmaceutical. Alternative Names: (1R)-N-[(4-Fluorophenyl)methyl]-2,3-dihydro-5-[[(methylamino)carbonyl]amino]-2',4'-dioxo-N-[(1S)-2,2,2-trifluoro-1-methylethyl]spiro[1H-indene-1,5'-oxazolidine]-3'-acetamide. CAS No. 1889279-16-6. Pack Sizes: 100 mg. Product ID: B1370-292260. Molecular formula: C25H24F4N4O5. Mole weight: 536.48. Custom synthesis is available. Send your inquiries for more information. | London |
| Abexinostat | Abexinostat, also known as PCI-24781 or CRA-024781, is a novel, broad-spectrum hydroxamic acid-based inhibitor of histone deacetylase (HDAC) with potential antineoplastic activity. Abexinostat inhibits several isoforms of HDAC, resulting in an accumulation of highly acetylated histones, followed by the induction of chromatin remodeling. Group: Pharmaceutical. Alternative Names: CRA-024781; CRA 024781; CRA024781; PCI-24781; PCI24781; PCI 24781. CAS No. 783355-60-2. Pack Sizes: 100 mg. Product ID: B2693-286637. Molecular formula: C21H23N3O5. Mole weight: 397.431. Custom synthesis is available. Send your inquiries for more information. | London |
| BAY 299 | BAY 299 is a potent and selective inhibitor of BRD1 and TAF1 (IC50 = 6-67 and 8-13 nM, respectively) with selectivity over other bromodomains (>30-fold over other members of the BRPF family; BRD9 and ATAD2; >300-fold over BRD4). BAY 299 suppresses binding of BRD1 and TAF1 to histone H4 (IC50 = 575 nM and 0.9 μM, respectively) and histone H3.3 (IC50 = 825 nM and 1.4 μM, respectively). Group: Pharmaceutical. Alternative Names: BAY-299; BAY 299; BAY299. 6-(3-Hydroxypropyl)-2-(1,3,6-trimethyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-yl)-1H-benzo[de]isoquinoline-1,3(2H)-dione. CAS No. 2080306-23-4. Pack Sizes: 25 mg. Product ID: B0084-119159. Molecular formula: C25H23N3O4. Mole weight: 429.47. Custom synthesis is available. Send your inquiries for more information. | London |
| Belinostat | Belinostat is a hydroxamic acid-type histone deacetylase (HDAC) inhibitor. Belinostat targets HDAC enzymes to inhibit tumor cell proliferation and angiogenesis, induce apoptosis and promote cellular differentiation. Uses: Antineoplastic agents. Group: Pharmaceutical. Alternative Names: Belinostat; PXD 101; Beleodaq; PDX101; PX 105684; PXD-101; PXD101; (E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide. CAS No. 414864-00-9. Pack Sizes: 100 mg. Product ID: B0084-141764. Molecular formula: C15H14N2O4S. Mole weight: 318.347. Custom synthesis is available. Send your inquiries for more information. | London |
| Bradykinin acetate salt | Bradykinin Acetate is a physiologically and pharmacologically active peptide of kinin histone, which is composed of nine amino acids. The pharmacological properties of bradykinin include smooth muscle contraction, vasodilation and hypotension, increased capillary permeability, edema formation and pain induction. It can cause bronchoconstriction and rhinitis symptoms of nasal irritation in asthmatics. Group: Pharmaceutical. Alternative Names: Bradykinin, acetate (1:x); Bradykinin, acetate (salt); H 1970; H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH.xCH3CO2H; L-arginyl-L-prolyl-L-prolyl-glycyl-L-phenylalanyl-L-seryl-L-prolyl-L-phenylalanyl-L-arginine acetate salt; L-Bradykinin acetate salt; Arginine, N2-[N-[1-[N-[N-[N-[1-(1-arginyl-L-prolyl)-L-prolyl]glycyl]-3-phenylalanyl]seryl]prolyl]-3-phenylalanyl]-, acetate salt; Bradykinin acetate. CAS No. 6846-3-3. Pack Sizes: 100 mg. Product ID: BAT-009050. Molecular formula: C50H73N15O11.xC2H4O2. Mole weight: 1060.21 (free base). Custom synthesis is available. Send your inquiries for more information. | London |
| C646 | C646 is an inhibitor for histone acetyltransferase, and inhibits p300 with a Ki of 400 nM. Preferentially selective for p300 versus other acetyltransferases. Group: Pharmaceutical. Alternative Names: C646; C-646; C 646. CAS No. 328968-36-1. Pack Sizes: 25 mg. Product ID: B0084-370250. Molecular formula: C24H19N3O6. Mole weight: 445.42. Custom synthesis is available. Send your inquiries for more information. | London |
| CBL0137 | CBL0137 is a metabolically stable curaxin that activates p53 with an EC50 value of 0.37 μM and inhibits NF-κB with an EC50 of 0.47 μM. It also inhibits histone chaperone FACT (facilitates chromatin transcription) and MYC signal. Group: Pharmaceutical. Alternative Names: CBL0137; CBL-0137; CBL 0137; CBLC137; CBLC-137; CBLC 137; Curaxin 137; 1,1'-(9-(2-(Isopropylamino)ethyl)-9H-carbazole-3,6-diyl)diethanone; 1-[6-acetyl-9-[2-(propan-2-ylamino)ethyl]carbazol-3-yl]ethanone. CAS No. 1197996-80-7. Pack Sizes: 2.5 mg. Product ID: B0084-284751. Molecular formula: C21H24N2O2. Mole weight: 336.435. Custom synthesis is available. Send your inquiries for more information. | London |
| CXD101 | CXD101 is a selective histone deacetylase (HDAC) inhibitor with IC50 of 63 nM, 570 nM and 550 nM for HDAC1, HDAC2 and HDAC3, respectively. It exhibits antineoplastic activity. Group: Pharmaceutical. Alternative Names: HDAC-IN-4; CXD-101; CXD 101; N-(2-Aminophenyl)-4-(1-((1,3-dimethyl-1H-pyrazol-4-yl)methyl)piperidin-4-yl)benzamide. CAS No. 934828-12-3. Pack Sizes: 10 mg. Product ID: B1370-379907. Molecular formula: C24H29N5O. Mole weight: 403.52. Custom synthesis is available. Send your inquiries for more information. | London |
| Disodium (R)-2-Hydroxyglutarate | Disodium (R)-2-Hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases with Ki of 0.628 mM. In U-87MG cells, (R)-2-Hydroxyglutarate acts as a weak antagonist of α-KG to inhibit α-KG-dependent histone demethylases and increase dimethylation on both H3K9 and H3K79. Group: Pharmaceutical. Alternative Names: MDK4906; MDK 4906; MDK-4906; d-α-hydroxyglutaric acid disodium salt; (2R)-2-Hydroxyglutaric Acid Disodium Salt; D-alpha-Hydroxyglutaric acid (disodium salt). CAS No. 103404-90-6. Pack Sizes: 100 mg. Product ID: BAT-008968. Molecular formula: C5H6Na2O5. Mole weight: 192.08. Custom synthesis is available. Send your inquiries for more information. | London |
| Entinostat | Entinostat is a histone deacetylase (HDAC) inhibitor displaying antiproliferative and antineoplastic effects. Entinostat induces cyclin-dependent kinase inhibitor 1A (p21/CIP1/WAF1), which slows cell growth, differentiation, and tumor development in vivo. Entinostat is potentially used as an antitumor drug in combination with other drugs like adriamycin, PARP inhibitors and Hsp90 inhibitors. Uses: Histone deacetylase inhibitors. Group: Pharmaceutical. Alternative Names: MS275; MS-275; MS 2275; SNDX275; SNDX-275; SNDX 275; Entinostat; pyridin-3-ylmethyl N-[[4-[(2-aminophenyl)carbamoyl]phenyl]methyl]carbamate. CAS No. 209783-80-2. Pack Sizes: 500 mg. Product ID: B0084-062759. Molecular formula: C21H20N4O3. Mole weight: 376.416. Custom synthesis is available. Send your inquiries for more information. | London |
| EPZ-6438 | EPZ-6438 is a potent, selective, and orally bioavailable small-molecule inhibitor of EZH2 enzymatic activity. EPZ-6438 induces apoptosis and differentiation specifically in SMARCB1-deleted MRT cells. Treatment of xenograft-bearing mice with EPZ-6438 leads to dose-dependent regression of MRTs with correlative diminution of intratumoral trimethylation levels of lysine 27 on histone H3, and prevention of tumor regrowth after dosing cessation. These data demonstrate the dependency of SMARCB1 mutant MRTs on EZH2 enzymatic activity and portend the utility of EZH2-targeted drugs for the treatment of these genetically defined cancers. EPZ-6438 is currently in clinical trials. Group: Pharmaceutical. Alternative Names: EPZ-6438; EPZ 6438; EPZ6438; E7438; E-7438; E 7438; Tazemetostat. CAS No. 1403254-99-8. Pack Sizes: 1 g. Product ID: B0084-462339. Molecular formula: C34H44N4O4. Mole weight: 572.75. Custom synthesis is available. Send your inquiries for more information. | London |
| GSK525762 | GSK525762A, also known as I-BET-762 and GSK525762, is a small molecule inhibitor of the BET (Bromodomain and Extra-Terminal) family of bromodomain-containing proteins with potential antineoplastic activity. Upon administration, the BET inhibitor GSK525762 binds to the acetylated lysine recognition motifs on the bromodomain of BET proteins, thereby preventing the interaction between the BET proteins and acetylated histone peptides. This disrupts chromatin remodeling and gene expression. Prevention of the expression of certain growth-promoting genes may lead to an inhibition of tumor cell growth. Characterized by a tandem repeat of bromodomain at the N-terminus, BET proteins, comprising of BRD2, BRD3, BRD4 and BRDT, are transcriptional regulators that play an important role during development and cellular growth. Group: Pharmaceutical. Alternative Names: GSK525762; GSK525762; GSK525762; GSK525762A; GSK-525762A; GSK 525762A; I-BET-762; I-BET762; I-BET 762; molibresib. CAS No. 1260907-17-2. Pack Sizes: 25 mg. Product ID: B2693-457801. Molecular formula: C22H22ClN5O2. Mole weight: 423.9. Custom synthesis is available. Send your inquiries for more information. | London |
| Inobrodib | Inobrodib is an inhibitor of the histone acetyltransferase p300 and CREB-binding protein and has antineoplastic activity. Group: Pharmaceutical. Alternative Names: (6S)-1-(3,4-difluorophenyl)-6-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-(trans-4-methoxycyclohexyl)-1H-benzimidazol-2-yl]piperidin-2-one; (S)-1-(3,4-difluorophenyl)-6-(5-(3,5-dimethylisoxazol-4-yl)-1-((1R,4S)-4-methoxycyclohexyl)-1H-benzo[d]imidazol-2-yl)piperidin-2-one; CBP-IN-1; CCS-1477; (6S)-1-(3,4-Difluorophenyl)-6-[5-(3,5-dimethyl-4-isoxazolyl)-1-(trans-4-methoxycyclohexyl)-1H-benzimidazol-2-yl]-2-piperidinone; CCS 1477; CCS1477. CAS No. 2222941-37-7. Pack Sizes: 5 mg. Product ID: B2693-373001. Molecular formula: C30H32F2N4O3. Mole weight: 534.6. Custom synthesis is available. Send your inquiries for more information. | London |
| M344 | M344 is a potent HDAC inhibitor, which can also induce expression of the pro-apoptotic genes, Puma and Bax, together with the morphological features of apoptosis, in MCF-7 cells. Group: Pharmaceutical. Alternative Names: M 344; M-344; Histone Deacetylase Inhibitor III. CAS No. 251456-60-7. Pack Sizes: 100 mg. Product ID: B1370-103604. Molecular formula: C16H25N3O3. Mole weight: 307.39. Custom synthesis is available. Send your inquiries for more information. | London |
| MAK683 | MAK683 is an inhibitor of embryonic ectoderm development protein (EED) with potential antineoplastic activity. MAK683 binds to the domain of EED that interacts with trimethylated lysine 27 on histone 3 (H3K27me3), leading to a conformational change in the EED H3K27me3-binding pocket and preventing the interaction of EED with the histone methyltransferase enhancer zeste homolog 2 (EZH2). MAK683 is undergoing phase II clinical trials for the identification of antitumor activity. Group: Pharmaceutical. Alternative Names: MAK-683; MAK 683; MAK683; EED inhibitor-1; N-[(5-fluoro-2,3-dihydro-1-benzofuran-4-yl)methyl]-8-(2-methylpyridin-3-yl)-[1,2,4]triazolo[4,3-c]pyrimidin-5-amine. CAS No. 1951408-58-4. Pack Sizes: 5 mg. Product ID: B0084-008118. Molecular formula: C20H17FN6O. Mole weight: 376.395. Custom synthesis is available. Send your inquiries for more information. | London |
| OICR 9429 | OICR-9429 can inhibit the interaction of WDR5 with peptide regions of MLL and histone 3 as a chemical probe. It can reduce viability of acute myeloid leukemia cells and can also disrupt MLL1-RbBP5 interaction. Group: Pharmaceutical. Alternative Names: OICR-9429; OICR 9429; OICR9429. N-[2-(4-Methylpiperazin-1-yl)-5-[3-(morpholin-4-ylmethyl)phenyl]phenyl]-6-oxo-4-(trifluoromethyl)-1,6-dihydropyridine-3-carboxamide. CAS No. 1801787-56-3. Pack Sizes: 100 mg. Product ID: B1370-054002. Molecular formula: C29H32F3N5O3. Mole weight: 555.59. Custom synthesis is available. Send your inquiries for more information. | London |
| Panobinostat | Panobinostat is a cinnamic hydroxamic acid analogue with potential antineoplastic activity. Panobinostat selectively inhibits histone deacetylase (HDAC), inducing hyperacetylation of core histone proteins, which may result in modulation of cell cycle protein expression, cell cycle arrest in the G2/M phase and apoptosis. In addition, this agent appears to modulate the expression of angiogenesis-related genes, such as hypoxia-inducible factor-1alpha (HIF-1a) and vascular endothelial growth factor (VEGF), thus impairing endothelial cell chemotaxis and invasion. HDAC is an enzyme that deacetylates chromatin histone proteins. Uses: Antineoplastic agents. Group: Pharmaceutical. Alternative Names: LBH589; LBH 589; LBH-589; NVP-LBH589; NVP-LBH 589; Panobinostat; trade name Farydak. CAS No. 404950-80-7. Pack Sizes: 500 mg. Product ID: B0084-141578. Molecular formula: C21H23N3O2. Mole weight: 349.434. Custom synthesis is available. Send your inquiries for more information. | London |
| Parasin I TFA | Parasin I, a 19-amino acid histone H2A-derived peptide isolated from the skin of the catfish, is a cell permeable cationic antimicrobial agent. Group: Pharmaceutical. Alternative Names: Parasin I trifluoroacetate salt; H-Lys-Gly-Arg-Gly-Lys-Gln-Gly-Gly-Lys-Val-Arg-Ala-Lys-Ala-Lys-D-aThr-Arg-Ser-Ser-OH.TFA. Pack Sizes: 5 mg. Product ID: BAT-016474. Molecular formula: C84H155F3N34O26. Mole weight: 2114.33. Custom synthesis is available. Send your inquiries for more information. | London |
| Pracinostat | Pracinostat (SB939) is an orally bioavailable, small-molecule histone deacetylase (HDAC) inhibitor with potential antineoplastic activity. Pracinostat inhibits HDACs, which may result in the accumulation of highly acetylated histones, followed by the induction of chromatin remodeling; the selective transcription of tumor suppressor genes; the tumor suppressor protein-mediated inhibition of tumor cell division; and, finally, the induction of tumor cell apoptosis. This agent may possess improved metabolic, pharmacokinetic and pharmacological properties compared to other HDAC inhibitors. Group: Pharmaceutical. Alternative Names: SB939; SB 939; SB-939; SC-939; SC 939; SC939; Pracinostat. CAS No. 929016-96-6. Pack Sizes: 1 g. Product ID: B0084-286706. Molecular formula: C20H30N4O2. Mole weight: 358.486. Custom synthesis is available. Send your inquiries for more information. | London |
| Rocilinostat | Rocilinostat is an orally bioavailable histone deacetylase 6 (HDAC6) inhibitor with potential antineoplastic activity. It selectively targets and binds to HDAC6, thereby disrupting the Hsp90 protein chaperone system through hyperacetylation of Hsp90 and preventing the subsequent aggresomal protein degradation. Compared to non-selective HDAC inhibitor, Rocilinostat is able to reduce the toxic effects on normal, healthy cells. Uses: Antineoplastic agents. Group: Pharmaceutical. Alternative Names: ACY-1215; ACY1215; ACY 1215; Rocilinostat; 2-(Diphenylamino)-N-(7-(hydroxyamino)-7-oxoheptyl)pyrimidine-5-carboxamide. CAS No. 1316214-52-4. Pack Sizes: 500 mg. Product ID: B0084-462644. Molecular formula: C24H27N5O3. Mole weight: 433.512. Custom synthesis is available. Send your inquiries for more information. | London |
| Tozasertib | The Aurora kinases (A, B, and C) are a family of serine-threonine kinases that regulate various stages of mitotic function. With significant roles in cell cycle and cell division, Aurora kinase gene amplification and overexpression are linked to tumorigenesis. MK 0457 is a potent pan-Aurora kinase inhibitor but favors Aurora A (Ki = 0.6 nM) over Aurora B (Ki = 18 nM) or Aurora C (Ki = 4.6 nM). It shows selectivity against a panel of more than 190 different protein kinases. MK 0457 effectively inhibits proliferation of several different cell lines of clear cell renal carcinoma (IC50s < 10 μM) and blocks the growth of tumors in a rodent model of cancer (80 mg/kg), inhibiting histone H3 phosphorylation and increasing apoptosis. By depleting Aurora activity, MK 0457 disrupts bipolar spindle formation during mitosis, arresting cell cycle progression at the G2/M phase. Group: Pharmaceutical. Alternative Names: VX680; VX 680; VX-680; MK0457; MK 0457; MK-0457; VE465; VE-465; VE 465; Tozasertib. CAS No. 639089-54-6. Pack Sizes: 250 mg. Product ID: B0084-074159. Molecular formula: C23H28N8OS. Mole weight: 464.59. Custom synthesis is available. Send your inquiries for more information. | London |
| TP 064 | TP 064 is a potent and selective PRMT4 inhibitor with >100-fold selectivity over other histone methyltransferases and non-epigenetic targets. TP 064 inhibits methylation of H3 (1-25) and MED12 in cellular assays (IC50 values are <10 and 43 nM, respectively). Group: Pharmaceutical. Alternative Names: TP-064; TP064; N-Methyl-N-((2-(1-(2-(methylamino)ethyl)piperidin-4-yl)pyridin-4-yl)methyl)-3-phenoxybenzamide. CAS No. 2080306-20-1. Pack Sizes: 25 mg. Product ID: B2693-170422. Molecular formula: C28H34N4O2. Mole weight: 458.6. Custom synthesis is available. Send your inquiries for more information. | London |
| Tucidinostat | Tucidinostat is a novel inhibitor of HDAC1, 2, 3, and 10 with IC50 values of 95, 160, 67, 78 nM, respectively. It increases the acetylation levels of histone H3 and decreases histone deacetylase (HDAC) activity, inducing apoptosis of cancer cells. Group: Pharmaceutical. Alternative Names: HBI-8000; CS-055; Chidamide; Epidaza. CAS No. 1616493-44-7. Pack Sizes: 25 mg. Product ID: B2693-292408. Molecular formula: C22H19FN4O2. Mole weight: 390.41. Custom synthesis is available. Send your inquiries for more information. | London |
| Vorinostat | Vorinostat (suberoylanilide hydroxamic acid, SAHA) is an HDAC inhibitor with IC50 of ~10 nM. Uses: Antineoplastic agents; histone deacetylase inhibitors. Group: Pharmaceutical. Alternative Names: MK-0683, MK 0683, MK0683, SAHA, M344, CCRIS 8456, HSDB 7930, Vorinostat, suberoylanilide hydroxamic acid, Zolinza. CAS No. 149647-78-9. Pack Sizes: 5 g. Product ID: B2693-059322. Molecular formula: C14H20N2O3. Mole weight: 264.3. Custom synthesis is available. Send your inquiries for more information. | London |
| (Z)-JIB-04 | (Z)-JIB-04 is a Z-isomer of JIB-04, which is a small-molecule histone demethylase inhibitor with antitumor activity. JIB-04 selectively inhibits tumor growth via targeting various tumorigenic signaling pathways. Group: Pharmaceutical. Alternative Names: 5-Chloro-2-(2-(phenyl(pyridin-2-yl)methylene)hydrazinyl)pyridine; JIB-04 Z-isomer. CAS No. 199596-24-2. Pack Sizes: 50 mg. Product ID: B0084-284797. Molecular formula: C17H13ClN4. Mole weight: 308.769. Custom synthesis is available. Send your inquiries for more information. | London |
| Dimetridazole | Dimetridazole is an anti-fungal and anti-protozoal drug. It is a nitroimidazole class drug. Dimenidazole is an effective anti-histonia and anti-treponema pallidum agent. Uses: Antibacterial and anticoccidial activity. Group: Pharmaceutical. Alternative Names: 1,2-dimethyl-5-nitro-1h-imidazole; TIMTEC-BB SBB006915; 1,2-dimethyl-5-nitro-1h-imidazol; 1,2-dimethyl-5-nitro-imidazol; 1H-Imidazole, 1,2-dimethyl-5-nitro-. CAS No. 551-92-8. Pack Sizes: 1mg;1g;10g. Product ID: BBF-03900. Molecular formula: C5H7N3O2. Mole weight: 141.13. Custom synthesis is available. Send your inquiries for more information. | London |
Our database is helping our users find suppliers everyday.
